CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: LCL161
Accession: CHEBI:193137
browse the term
Definition: LCL161 is a small molecule inhibitor of IAPs that has potent antitumour activity in a range of solid tumours. In HCC, response to LCL161 therapy has shown to be mediated by Bcl-2 expression.
Synonyms: exact_synonym: N-[(1S)-1-cyclohexyl-2-{(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl}-2-oxoethyl]-N(2)-methyl-L-alaninamide
related_synonym: (2S)-N-[(1S)-1-cyclohexyl-2-{(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl}-2-oxoethyl]-2-(methylamino)propanamide; (s)-n-((s)-1-cyclohexyl-2-((s)-2-(4-(4-fluorobenzoyl)thiazol-2-yl)pyrrolidin-1-yl)-2-oxoethyl)-2-(methylamino)propanamide; Formula=C26H33FN4O3S; InChI=1S/C26H33FN4O3S/c1-16(28-2)24(33)30-22(17-7-4-3-5-8-17)26(34)31-14-6-9-21(31)25-29-20(15-35-25)23(32)18-10-12-19(27)13-11-18/h10-13,15-17,21-22,28H,3-9,14H2,1-2H3,(H,30,33)/t16-,21-,22-/m0/s1; InChIKey=UFPFGVNKHCLJJO-SSKFGXFMSA-N; Lcl-161; NVP-LCL161; SMILES=[H][C@]1(CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC)C1CCCCC1)C1=NC(=CS1)C(=O)C1=CC=C(F)C=C1
xref: CAS:1005342-46-0
xref_mesh: MESH:C574246
xref: PMID:22580047; PMID:24976294; PMID:26846923; PMID:27043662; PMID:27640787; PMID:27737687; PMID:29455885; PMID:30235087; PMID:30530779; PMID:31015310; PMID:31138375; PMID:31521127; PMID:31908904; PMID:32497533; PMID:34398333; PMID:34424319; PMID:34496878; PMID:35007560; PMID:35098674; PMID:36286042; PMID:36531039; PMID:36686801; PMID:37129455; PMID:37138866; PMID:37513508; PMID:37524969
G
Abcb1a
ATP binding cassette subfamily B member 1A
multiple interactions
ISO
LCL161 binds to and affects the activity of ABCB1 protein; LCL161 inhibits the reaction [ABCB1 protein results in increased export of Fluorescent Dyes]; LCL161 inhibits the reaction [ABCB1 protein results in increased export of mitotracker green FM]
CTD
PMID:32497533
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Birc2
baculoviral IAP repeat-containing 2
decreases expression decreases expression
ISO
LCL161 results in decreased expression of BIRC2 protein LCL161 decreases expression of BIRC2 protein in hepatocellular carcinoma cells
CTD RGD
PMID:32497533 PMID:24976294
RGD:153305953
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
G
Birc3
baculoviral IAP repeat-containing 3
decreases expression
ISO
LCL161 decreases expression of BIRC3 protein in hepatocellular carcinoma cells
RGD
PMID:24976294
RGD:153305953
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
G
Birc5
baculoviral IAP repeat-containing 5
decreases expression
ISO
LCL161 results in decreased expression of BIRC5 protein
CTD
PMID:32497533
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
G
Xiap
X-linked inhibitor of apoptosis
decreases expression
ISO
LCL161 decreases expression of XIAP protein in hepatocellular carcinoma cells
RGD
PMID:24976294
RGD:153305953
NCBI chr X:120,890,537...120,938,413
Ensembl chr X:120,897,907...120,934,700
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all